Literature DB >> 16614125

Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002).

Kimberly Irby1, William F Anderson, Donald E Henson, Susan S Devesa.   

Abstract

BACKGROUND: Colorectal carcinoma (CRC) is the fourth most common cancer diagnosed and the second most common cause of cancer death in the U.S. Incidence and mortality rates have decreased since the mid-1980s, although more among Whites than Blacks.
METHODS: To determine if these racial differences were changing over time, we examined CRC rates in the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program (1975-2002). Rates were stratified by gender, race, anatomic subsite, historic stage, and grade.
RESULTS: CRC rates were higher among men than women and higher among Blacks than Whites, with Black men having the highest rates during the latter years. Prior to the mid-1980s, male CRC rates were actually higher among Whites than Blacks; after which there was ethnic crossover with Black rates higher than White rates, and the gaps are widening. Proximal and transverse CRCs were more common and rectal cancers were less common among Blacks than Whites. Over time, rates for localized and regional stages increased among Blacks and decreased among Whites. Rates for distant stages declined for both racial groups, although less among Blacks. Black-to-White rate ratio for distant stage was approximately 1.30. Notably, Blacks compared with Whites had lower grade tumors, despite higher stages and mortality rates.
CONCLUSIONS: CRC racial disparities have emerged and widened for three decades. These temporal trends probably reflect complicated racial differences between screening practice patterns and etiologic factors.

Entities:  

Mesh:

Year:  2006        PMID: 16614125     DOI: 10.1158/1055-9965.EPI-05-0879

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  56 in total

1.  Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults.

Authors:  Christina D Mack; William Carpenter; Anne-Marie Meyer; Hanna Sanoff; Til Stürmer
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

2.  Sex disparities in colorectal cancer incidence by anatomic subsite, race and age.

Authors:  Gwen Murphy; Susan S Devesa; Amanda J Cross; Peter D Inskip; Katherine A McGlynn; Michael B Cook
Journal:  Int J Cancer       Date:  2010-05-25       Impact factor: 7.396

3.  Racial disparities in stage-specific colorectal cancer mortality: 1960-2005.

Authors:  Samir Soneji; Shally Shalini Iyer; Katrina Armstrong; David A Asch
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

4.  Patient activation increases colorectal cancer screening rates: a randomized trial among low-income minority patients.

Authors:  Mira L Katz; James L Fisher; Kelly Fleming; Electra D Paskett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-08       Impact factor: 4.254

5.  Colorectal cancer screening awareness and intentions among low income, sociodemographically diverse adults under age 50.

Authors:  Karen Emmons; Elaine Puleo; Lorna H McNeill; Gary Bennett; Sophia Chan; Sapna Syngal
Journal:  Cancer Causes Control       Date:  2008-05-14       Impact factor: 2.506

6.  Outcomes Among Minority Patients With Metastatic Colorectal Cancer in a Safety-net Health Care System.

Authors:  Kelsey Lau-Min; Preeti Prakash; Eunji Jo; Aaron P Thrift; Susan Hilsenbeck; Benjamin L Musher
Journal:  Clin Colorectal Cancer       Date:  2020-01-02       Impact factor: 4.481

7.  What factors influence minority use of National Cancer Institute-designated cancer centers?

Authors:  Lyen C Huang; Yifei Ma; Justine V Ngo; Kim F Rhoads
Journal:  Cancer       Date:  2013-10-21       Impact factor: 6.860

Review 8.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

9.  Trout ova, an alternative source of anti-B.

Authors:  P Rees; R Cotton; P D Holt; D J Anstee
Journal:  Med Lab Sci       Date:  1976-01

Review 10.  Colorectal cancer, one entity or three.

Authors:  Feng-ying Li; Mao-de Lai
Journal:  J Zhejiang Univ Sci B       Date:  2009-03       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.